Le Lézard
Classified in: Health
Subjects: RCL, CFG

Food Recall Warning - Pacific Rim Shellfish (2003) Corp brand Oysters recalled due to norovirus


OTTAWA, ON, March 27, 2022 /CNW/ -

Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/pacific-rim-shellfish-2003-corp-brand-oysters-recalled-due-norovirus

Summary
Affected products

Brand

Product

Size

UPC

Codes

Pacific Rim
Shellfish (2003)
Corp

XSM Tray
Oyster

Variable
(clerk-served)

None

Harvest Location BC 14-15

Lease # 1400036

 

Harvest Date:

  • March 9, 2022,
  • March 15, 2022, &
  • March 19, 2022

 

Pacific Rim
Shellfish (2003)
Corp

XSM Beach
Oyster

Variable
(clerk-served)

None

Harvest Area BC 14-15

Lease # 1400036

Harvest Date:

  • March 9, 2022 &
  • March 15, 2022

 

Pacific Rim
Shellfish (2003)
Corp

MLarge Tray
Oyster

Variable
(clerk-served)

None

Harvest Area BC 14-15

Lease # 1400036

Harvest Date: March 9, 2022

 

Pacific Rim
Shellfish (2003)
Corp

MLarge Beach
Oyster

Variable
(clerk-served)

None

Harvest Area BC 14-15

Lease # 1400036

Harvest Date: March 15, 2022

 

Issue

Pacific Rim Shellfish (2003) Corporation is recalling Pacific Rim Shellfish (2003) Corp brand Oysters from the marketplace due to possible norovirus contamination.

The recalled products have been sold in British Columbia, Alberta, Saskatchewan, Manitoba, Yukon, and Ontario and may have been distributed in other provinces and territories.

What you should do

People with norovirus illness usually develop symptoms of gastroenteritis within 24 to 48 hours, but symptoms can start as early as 12 hours after exposure. The illness often begins suddenly. Even after having the illness, you can still become re-infected by norovirus. The main symptoms of norovirus illness are diarrhea, vomiting (children usually experience more vomiting than adults), nausea and stomach cramps. Other symptoms may include low-grade fever, headache, chills, muscle aches and fatigue (a general sense of tiredness).  Most people feel better within one or two days, with symptoms resolving on their own, and experience no long-term health effects. As with any illness causing diarrhea or vomiting, people who are ill should drink plenty of liquids to replace lost body fluids and prevent dehydration. In severe cases, patients may need to be hospitalized and given fluids intravenously.

Learn more:

Background

This recall was triggered by findings of the Canadian Food Inspection Agency during its investigation into a foodborne illness outbreak.

There have been reported illnesses associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.

The CFIA is verifying that industry is removing the recalled products from the marketplace.

Également disponible en français

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 08:00
Kane Biotech Inc. (the "Company" or "Kane Biotech"), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will release its first quarter 2024...

at 08:00
Cannabix Technologies Inc. (the "Company" or "Cannabix") reports that it has entered into a strategic partnership and development agreement dated May 15, 2024 (the "Agreement") with Omega Laboratories Inc of Ohio, USA ("Omega Laboratories" or...

at 07:35
Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced it will conduct a Type B End-of-Phase 2 (EOP2) meeting in July with the U.S. Food and Drug Administration (FDA) to...

at 07:35
Zai Lab Limited today announced that members of the Company's senior management team will participate in the following investor conferences in May and June 2024: J.P. Morgan 20th Annual Global China Summit Panel Discussion: Thursday, May 23, 2024,...

at 07:35
Johnson & Johnson announced today that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with...

at 07:35
Biogen Inc. and Ionis Pharmaceuticals, Inc. ...



News published on and distributed by: